title: Postoperative changes in the plasmatic levels of tissue-type plasminogen activator and its fast-acting inhibitor--relationship to deep vein thrombosis and influence of prophylaxis.
abstract: Fibrinogen, euglobulin lysis time (ELT), tissue-type plasminogen activator (t-PA) antigen, plasminogen activator inhibitor activity (PA-inhibitor) and alpha 2-antiplasmin (alpha 2-AP) were measured pre- and postoperatively in 60 patients undergoing total hip replacement. Reduced fibrinolytic activity as assessed by the prolongation of euglobulin lysis time, decrease of t-PA and increase of PA-inhibitor and alpha 2-AP could be demonstrated. These changes did not correlate with the postoperative deep vein thrombosis (DVT) diagnosed with the 125I-fibrinogen test. However, preoperative PA-inhibitor activity was significantly higher in patients with postoperative DVT (p less than 0.01). The prophylactic treatment with aspirin (20 patients) and with heparin plus dihydroergotamine (20 patients) induced significant changes in some of those parameters. This study shows that the decrease of t-PA and the increase of PA-inhibitor may contribute to the reduced postoperative fibrinolytic activity after total hip replacement. PA-inhibitor level might be a useful marker in evaluating the risk of developing DVT in patients undergoing total hip replacement.
mesh_terms: D001241:Aspirin / Q000627:therapeutic use; D004087:Dihydroergotamine / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005340:Fibrinogen / Q000097:blood; D006023:Glycoproteins / Q000097:blood*; D006493:Heparin / Q000627:therapeutic use; D006622:Hip Prosthesis; D006801:Humans; D010960:Plasminogen Activators / Q000097:blood*; D015849:Plasminogen Inactivators; D011183:Postoperative Complications / Q000097:blood*; D013924:Thrombophlebitis / Q000097:blood* / Q000517:prevention & control; D010959:Tissue Plasminogen Activator / Q000097:blood*; D000979:alpha-2-Antiplasmin / Q000097:blood
chemical_list: D006023:Glycoproteins; D015849:Plasminogen Inactivators; D000979:alpha-2-Antiplasmin; D004087:Dihydroergotamine; D005340:Fibrinogen; D006493:Heparin; D010960:Plasminogen Activators; D010959:Tissue Plasminogen Activator; D001241:Aspirin